Diadema Partners »

Oruka Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Oruka Therapeutics (ORKA) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Oruka Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Oruka Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oruka Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 28k 95.17

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Oruka Therapeutics

FMR
BlackRock
VR Adviser
Fairmount Funds Management
Rtw Investments
Vanguard Capital Management
Paradigm Biocapital Advisors
Deep Track Capital
Bellevue Group
Franklin Resources
State Street Corporation
Remedium Capital Partners
RA Capital Management
Viking Global Investors
Geode Capital Management

View all funds holding Oruka Therapeutics